Splenosis imaging with 99mTc nano-colloid as a different mimicker in a lymphoma patient on 18F- FDG PET/CT; [Scintigraphie aux nanocolloïdes-33mTc pour différencier une splénose d'un ganglion lymphatique fixant le 18F-FDG]
No Thumbnail Available
Date
2024
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Fluorodeoxyglucose (FDG) 18F-FDG PET/CT plays an important role in lymphoma staging and evaluation of treatment response. Mimics should be considered when evaluating 18F-FDG PET/CT images to perform correct staging and correct treatment response evaluation. Splenosis is one of the causes that may cause misinterpretation by mixing with lymph nodes in lymphoma patients. In our case report, we visualized splenosis mimicking lymph node in a 50-year-old lymphoma patient with 99mTc nano-colloid scintigraphy. © 2024 Elsevier Masson SAS
Description
Keywords
cyclophosphamide plus doxorubicin plus prednisolone plus rituximab plus vincristine , fluorodeoxyglucose f 18 , nanocolloid , technetium 99m , adult , Article , cancer chemotherapy , cancer patient , cancer recurrence , cancer staging , case report , clinical article , clinical evaluation , diffuse large B cell lymphoma , follow up , hospital department , human , human tissue , lung nodule , lymph node biopsy , male , medical history , middle aged , multiple cycle treatment , nephrectomy , patient history of surgery , physical examination , positron emission tomography-computed tomography , recurrent disease , remission , scintigraphy , single photon emission computed tomography , spleen injury , spleen tissue , splenectomy , swelling , traffic accident , treatment response , ultrasound guided biopsy